Glyburide Tablets
Company: Mylan Laboratories
Approval Status: Approved July 1998.
Treatment for: Diabetes Mellitus
Areas: Endocrinology
Possible similar drugs: Glyburide Tablets; Glyburide Tablets
General Information
Other Useful Resources
Glyburide tablets in both 1.5 and 3mg strengths have recently been approved to be used as an adjunct to diet to lower the blood glucose level in patients with non-insulin dependent Diabetes Mellitus (Type II), whose Hyperglycemia cannot be controlled by diet alone.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
